Intestinal microbial dysbiosis has been described in individuals with an HIV-1 infection and may underlie persistent inflammation in chronic infection, thereby contributing to disease progression. Herein, we induced an HIV-1-like intestinal dysbiosis in rhesus macaques (Macaca mulatta) with vancomycin treatment and assessed the contribution of dysbiosis to SIV disease progression. Dysbiotic and control animals had similar disease progression, indicating that intestinal microbial dysbiosis similar to that observed in individuals with HIV is not sufficient to accelerate untreated lentiviral disease progression.
Intestinal microbial dysbiosis has been described in individuals infected with progressive HIV-1. This dysbiosis includes enrichment of Proteobacteria (particularly Enterobacteriaceae) and Erysipelotrichaceae, coincident with declines in Clostridia and Bacteroides 1 . Dysbiotic taxa in infected individuals correlate with persistent inflammation-a hallmark of progressive infection 2 . However, an empirical assessment of the contribution of microbial dysbiosis to disease progression is lacking. Recent data suggest that risk factors for HIV-1 acquisition can also result in microbial dysbiosis 3 , and although SIV nonhuman primate (NHP) models for HIV-1 infection recapitulate salient features of infection 4 , dysbiosis is not consistently observed 1, 5 .
In healthy NHPs, vancomycin inhibits the growth of Grampositive bacteria, inducing a dysbiosis similar to that described in HIV-1 infection ( Supplementary Fig. 1 ). To assess whether intestinal dysbiosis accelerates lentiviral disease progression, we treated seven rhesus macaques (RMs) with vancomycin for 5 d every 28 d, beginning 56 d pre-SIV infection ( Fig. 1a ) and then infected these and six control animals with SIV mac239 . Following treatment, fecal microbiome diversity became increasingly disparate between groups, with vancomycin-treated (Vanco) monkeys exhibiting reduced α -diversity (taxa richness and evenness within a group) and increased β -diversity (phylogenetic distance of taxa between groups) compared to control monkeys ( Fig. 1b and Supplementary Fig. 2a ). No differences in total bacterial DNA recovery were observed between groups ( Supplementary Fig. 2b ).
Gram-positive Firmicutes dominated the fecal microbiome irrespective of treatment; however, relative Firmicute frequencies in Vanco monkeys decreased ( Supplementary Fig. 2c ). While control animals had comparable distributions of Clostridia and Bacilli among Firmicutes, Firmicutes recovered from Vanco animals were enriched in Bacilli (Fig. 1c ). Importantly, Vanco animals displayed increasing Proteobacteria frequencies postinfection ( Supplementary Fig. 2c ). Control animals had even distributions of Proteobacteria classes at day 115 postinfection (d115 p.i.), whereas Proteobacteria isolated from Vanco animals were enriched for Gammaproteobacteria ( Fig. 1d ). Epithelial-associated communities isolated from the intestines of Vanco animals displayed similar enrichments for Proteobacteria relative to Firmicutes ( Supplementary Fig. 2d ).
Of 390 operational taxonomic units (OTUs) identified, 256 features were differentially present between control and Vanco animals at d115 p.i., as identified by linear discriminant analysis (LDA)effect size (LEFSE) algorithm ( Fig. 1e, Supplementary Fig. 3 , and Supplementary Dataset 1). The phylum Proteobacteria was enriched in Vanco monkeys, and these enrichments were primarily driven by differences in Gammaproteobacteria (especially Enterobacteriaceae) and Deltaproteobacteria. In Vanco monkeys, LEFSE confirmed an enrichment of Bacilli and a depletion of Clostridia-particularly Lachnospiraceae and Ruminococcaceae-and Erysipelotrichaceae among Firmicutes, while among Bacteroidetes, Bacteroidales and a subcluster of families were also moderately depleted. Principle coordinate analysis (PCoA) of identified operational taxonomic units (OTUs) at d115 p.i. revealed clustering of microbial communities by treatment ( Fig. 1f ). Longitudinal quantification of Lachnospiraceae, Ruminococcaceae, Erysipelotrichaceae and Enterobacteriaceae confirmed persistent alterations in Vanco monkeys ( Supplementary  Fig. 2e ,f). Imputed metagenomic analysis revealed nondistinct fecal metagenomes between the groups at baseline ( Supplementary Fig. 4) , with a notable enrichment for metabolic and virulence pathways in Vanco monkeys at d115 p.i. Short-chain fatty acids (SCFA)microbial-produced metabolites important for gastrointestinal (GI) immunity and epithelial barrier maintenance 6,7 -were perturbed in Vanco monkeys, with significant disruptions from baseline observed for fecal valeric and hexanoic acids at d198 p.i. (Fig. 1g ).
To assess interdependency of intestinal microbial dysbiosis and lentiviral disease progression, we first assessed the integrity of the
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intestinal epithelium. Using immunohistochemical (IHC) staining for the tight junction protein Claudin-3, we observed reduced integrity of the colonic barrier in Vanco monkeys at necropsy (24.57% absence Claudin-3 continuity in Vanco as compared to 6.602% in controls; 95% CI, 10.18-25.75; P = 0.0004; Fig. 2a ). We next measured canonical parameters of disease progression. We found comparable: (i) CD4 + T cell counts and intestinal CD4 + T cell frequencies ( Fig. 2b and Supplementary Fig. 5a ), (ii) plasma viral loads ( Fig. 2c ); (iii) memory CD4 + T cell (TM)-associated viral DNA ( Fig. 2c and Supplementary Fig. 5b ); and (iv) an equivalent depletion of intestinal CD4 + TM expressing the HIV/SIV coreceptor, CCR5 ( Supplementary Fig. 5c ), irrespective of treatment.
We next assessed whether intestinal microbial dysbiosis may impact immune activation by measuring phenotypic and functional markers of T cells by flow cytometry. Between groups, isolated differences in cell-surface activation markers were observed in intestinal TM during acute infection ( Supplementary Fig. 5c,d ).
Although stimulated jejunal CD8 + TM from Vanco monkeys displayed significant reductions in mitogen-induced interferon (IFN)-γ and tumor necrosis factor (TNF)-α at several time points ( Supplementary Fig. 6a -c), these changes were not paired with differences in inhibitory programmed cell death protein (PD)-1 (ref. 8 ) nor polyfunctionality 9 ( Supplementary Fig. 6d,e ), suggesting that intestinal microbial dysbiosis did not modulate immune activation.
To assess whether intestinal microbial dysbiosis increases microbial translocation, we measured Escherichia coli in the colonic lamina propria, mesenteric lymph nodes (MLN), and livers of monkys by IHC and levels of plasma soluble CD14 (sCD14) and interleukin (IL)-6 by ELISA. Although both groups displayed evidence of translocation and elevated IL-6 ( Fig. 2d-f ), there were no differences between groups. The Vancomycin-induced depletion of SCFA-producing commensal Clostridia-taxa important for induction and maintenance of antimicrobial lymphocytes-may predispose Vanco animals to the emergence of opportunistic infections by hindering the development or maintence 6 of IL-17-expressing CD4 + TM (T H 17), CD8 + TM (T C 17) and NKp44 + innate lymphoid cells type-3 (ILC-3s) 5 . Despite differing Clostridia frequencies, we observed equivalent postinfection depletions of these subsets irrespective of treatment ( Fig. 2f,g and Supplementary Fig. 6 f) and a comparable presentation of secondary infections at necropsy (Supplementary Table 1 ).
In accordance with a lack of evidence for exacerbated immune dysfunction or microbial translocation, survival curves were comparable between groups, with control monkeys and and vancomycin-treated animals exhibiting a mean survival of 310 d.p.i. and 346 d.p.i., respectively ( Fig. 2h ; Mantel-Cox P = 0.33; Hazard Ratio = 0.6042 compared to control; 95% CI. 0.192-1.902). Findings documented at necropsy included thrombosis, lymphadenopathy, and secondary infection ( Supplementary Table 1 ); however, outcomes and blood cell counts ( Supplementary Fig. 7 ) did not differ by group.
SIV infection of RMs recapitulates key aspects of HIV-1 infection 4 . Although the gut microbial communities of RMs and humans share several dominant taxa, they differ substantially beyond the 0.005 between groups at baseline. h, Mean frequency of colon NKp44 + ILC3 at necropsy. i, Survival curve depicting time to death. Samples were longitudinally accessed from n = 6 and 7 for control and vancomycin-treated animals respectively, except for: d198 (n = 6 and 6); in c, where time points ≥ d198p.i. depict mean viremia for all surviving animals; in g, at d-68 and d14 (n = 6 and 6), d0 (n = 5 and 6), d28 (n = 3 and 4), and d115 (n = 5 and 7); and in h (n = 6 and 6). Longitudinal lines represent mean and include ± s.e.m. where individual data points are not shown. Statistical significance between groups was assessed by unpaired, two-way t-test. Survival significance in i was assessed by Mantel-Cox. genus classification 10 . We cannot discount that underappreciated differences in viral, host, or commensal identity may uniquely contribute to lentiviral disease progression in human and NHPs; however, largely parallel disease progression between the two argues that shared mechanisms are responsible. Our data does not preclude a role for intestinal dysbiosis in lentiviral transmission 11 , nor does it exclude a contribution of alternative dysbioses to lentiviral disease progression. Our data do, however, demonstrate that neither substantial upheaval of the intestinal microbiome nor enrichment for Proteobacteria at the expense of Clostridia are sufficient for accelerating disease progression.
Conceivably, immune dysfunction resulting from viral replication may overshadow intestinal dysbiosis in individuals with an HIV infection, and microbial translocation may be saturated. Importantly, intestinal dysbiosis may contribute to inflammation observed in highly active antiretroviral therapy (HAART)-treated individuals. This premise is supported by improved disease progression in HAART-treated RMs receiving additional microbiomemediated therapeutics. Thus far, however, similar efficacy has not been achieved in placebo-controlled human trials. Whereas probiotic treatment in humans with an HIV infection promotes promotes modest improvements in T cell activation and CD4 + T cell reconstitution, preliminary attempts toward fecal microbial transplantation have shown limited engraftment 12, 13 .
In conclusion, we demonstrate that experimentally induced intestinal dysbiosis in SIV-infected RMs does not accelerate disease progression. Dysbiotic and control animals exhibited comparable viremia, target-cell depletion, immune activation, microbial translocation, and ultimately, survival rates. These data indicate that intestinal microbial dysbiosis similar to that observed in HIV-infected individuals is not sufficient to accelerate untreated disease progression. We do not know how or whether vancomycin influenced the composition of the virome or mycobiome, both of which could influence inflammation 1, 14 . Further studies are required to unravel the circumstances surrounding intestinal dysbiosis in patients with an HIV infection and to determine whether components of specific dysbioses contribute to HIV transmission or therapeutic immune reconstitution.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41591-018-0132-5.
Animals and vancomycin treatment. Thirteen healthy rhesus macaques (Macaca mulatta), aged 6-15 years, were assigned to a control (n = 6, 5 of 6 were male) or vancomycin treatment (n = 7, all male) group, with sample size based on previous studies of experimental manipulations of disease progression in the macaque model. Groups were stratified by weight and genotype (Mamu-A*001, -A*002, -B*017, and -B*029) and animals sampled as mixed populations. Vancomycintreated animals received vancomycin hydrochloride (Pfizer, 10 mg per kg body weight (mg/kg), per os (p.o.)) for 5 d approximately every 28 d, beginning 56 d before infection. All animals were infected with 3,000 tissue culture infectious dose (TCID 50 ) SIV mac239 intravenously (i.v.) at d0 and were followed until clinical endpoints were met.
The NIAID Division of Intramural Research Animal Care and Use Program, as part of the NIH Intramural Research Program, approved all experimental procedures (protocol LVD 26). The program complies with all applicable provisions of the Animal Welfare Act and other federal statutes and regulations relating to animals.
Animals were housed and cared for at the NIH Animal Center, under the supervision of the Association for the Assessment and Accreditation of Laboratory Animal Care (AAALAC)-accredited Division of Veterinary Resources and as recommended by the Office of Animal Care and Use Nonhuman Primate Management Plan. Husbandry and care met the standards set forth by the Animal Welfare Act, Animal Welfare Regulations, as well as The Guide for the Care and Use of Laboratory Animals (8th Edition). The physical conditions of the animals were monitored daily. Animals in this study were exempt from contact social housing due to scientific justification, per institutional animal care and use committee (IACUC) protocol, and were housed in noncontact, social housing where primary enclosures consisted of stainless steel primate caging. Animals were provided continuous access to water and offered commercial monkey biscuits twice daily, as well as fresh produce, eggs, and bread products twice weekly and a foraging mix consisting of raisins, nuts, and rice thrice weekly. Enrichment to stimulate foraging and play activity was provided in the form of food puzzles, toys, cage furniture, and mirrors.
Sample Collection. Blood, tissue, stool, and luminal swab measurements are the result of a single sample per time point. Sampling occurred in the mornings and in random order, at predetermined time points as in Fig. 1a or upon meeting endpoint criteria as discussed below. Biopsies were maintained in RPMI before processing. For longitudinal lymph node (LN) biopsies, axillary or inguinal LNs were locally exposed and excised by blunt dissection. For longitudinal RBs, fecal material was removed from the rectum and biopsies obtained with biopsy forceps. Jej biopsies were obtained by video-guided endoscopy. Biopsies collected at necropsy were directly accessed immediately post mortem. Stool was collected fresh from the colon of each animal, and post mortem luminal swabs were obtained by the swabbing of exposed luminal contents of intestinal tissues. Plasma was isolated from blood by centrifugation. Mononuclear cells were isolated from blood by Ficoll gradient centrifugation and from tissue biopsies by passing samples through a 0.22-μ m cell strainer, with the exception of necropsy-obtained intestinal tissues. Endpoint jejunal and colonic biopsies (approximately 4 inches each) were mechanically and enzymatically digested in 120 mL of digestion media (RPMI supplemented to 10% FCS, 100 U/mL penicillin, 100 μ g/mL streptomycin sulfate, 1.7 mM sodium glutamate, 0.1% Liberase (Sigma), and 1000 U of DNAse I) for 1 h at 37 °C using a gentleMACS dissociator (Miltenyi) at 20 r.p.m., followed by treatment with 2 mM dithiothreitol for 15 min at 37 °C, followed by 0.22-μ m cell strainer filtration. Neither the investigators nor the animal handlers were blinded to group allocation in order to ensure multilateral supervision of design and palliative treatment. Animals were sedated with ketamine HCL at 10 mg/kg intramuscularly (i.m.) for longitudinal blood sampling or with Telazol at 3-4 mg/kg i.m. for tissue time points. For jejunal biopsies, animals were further anesthetized with isoflurane gas by intubation, to effect. Successful anesthetization was monitored by response to stimuli.
Endpoint criteria included presentation of any of the following: (i) loss of 25% body weight from baseline weight when assigned to the protocol, (ii) major organ failure or medical conditions unresponsive to treatment, (iii) complete anorexia for 4 d or an inability to feed or drink sufficient nutrients to maintain body weight without assistance for 7 d, (iv) distress vocalization unresponsive to treatment or intervention for 7 d, or (v) tumors arising from other than experimental means that grew in excess of 10% of body weight, impaired movement, or ulcerated. Euthanasia was initiated at clinical or experimental endpoints using protocols consistent with the American Veterinary Medical Association (AVMA) guidelines. Animals were first sedated with Telazol at 4 mg/kg i.m., followed by Pentobarbital at 80 mg/kg to achieve euthanasia.
Immune phenotyping and functional assessment. Polychromatic flow cytometry and cell sorting were performed on stained mononuclear cells as previously described 15 . Antibodies against the following antigens were used for staining at predetermined concentrations: CD4 (clone OKT4), CD8 (SK1), IFN-γ (4S.B3), IL-17 (eBio64DEC17), IL-21 (3A3-N2), IL-22 (IL22JOP), TNF-α (MAb11), and PD-1 (J105) from eBioscience; CCR5 (3A9), CD3 (SP34-2), CD8 (SK1), CD16 (HI149), CD20 (2H7), CD23 (M-L233), CD45 (D058-1283), CD123 (7G3), and HLA-DR (L243) from BD; c-Kit (104D2), CD1a (HI149), CD11c (3.9), CD14 (M5E2), CD34 (561), CD95 (DX2), and IL-2 (MQ1-17H12) from Biolegend; CD127 (eBioRDR5) and CD218a (H44) from Thermo; NKp44 (2.9) from Miltenyi; and CD28 (CD28.2) from Beckman Coulter. CD4 + and CD8 + TMs were defined as CD95 + singlet, clean, live, CD3 + lymphocytes. NKp44 + ILC3s were defined as CD45 + singlet, clean, live, lineage-negative (CD1a, CD3, CD8, CD11c, CD14, CD16, CD20, CD23, CD34, CD123), NKp44 + CD127 + CD218 + lymphocytes. Positive and negative gating was based on clearly grouped populations, historically determined expression, and the use of internal controls ( Supplementary Fig. 8) . A threshold of 100 collected events in the parent population was used for all subset expression analysis.
16S isolation and analysis. DNA was isolated from 250 mg of stool using the PowerLyzer PowerSoil DNA isolation kit (MO BIO) substituting stool for soil during the initial processing steps. Samples were homogenized on a Precellys 24 (Bertin Technologies). The Biomek NK P (Beckman Coulter) was used to facilitate automated, high-throughput processing via the PowerSoil manufacturer's protocol, substituting column binding with PowerMag magnetic beads and a magnetic plate (Alpaqua) on Corning 96 Deep-Well Assay Blocks (Fisher Scientific) to improve DNA retention throughout processing. 16S DNA was amplified from 50-100 ng total DNA using barcoded universal primers spanning basepairs 515(F)-806(R) of the 16s rRNA V4 region. 16S amplicons were subjected to Agencourt AMPure XP PCR Purification (Beckman Coulter no. A63882). > 1 ng 16S amplicons quantified using the 16S MiSeq (Illumina) platform. Returned FASTQ, paired-end reads were processed using QIIME 16 (v1.9.1) through the NIAID/NIH Microbiome Analysis Platform, Nephele (Office of Cyber Infrastructure and Computational Biology/ NIAID/NIH; http://nephele.niaid.nih.gov), and reads were truncated before 3 consecutive bases having Phred quality scores below 20. OTUs were classified by open reference using SILVA_99, and data were rarefied at 1,000 reads per sample. First-run, incomplete 16S miSeq time points were re-run in full with banked stool and duplicate returns averaged per time point as listed in the NCBI Sequence Read Archive (SRA) under project number PRJNA417022. For metagenomic analysis, OTUs were reclassified by closed reference using Greenegenes_99, and metagenomic profiles predicted by PICRUSt 17 Immunohistochemistry and quantitative image analysis. Formaldehyde fixed, paraffin-embedded (FFPE) tissue sections, 5-μ m thick, were placed on Fisher-Plus microscope slides, deparaffinized in xylenes, rehydrated through graded ethanols and subjected to HIER with 0.01% citraconic anhydride (Sigma-Aldrich; 125318), then cooled and washed in double distilled H 2 0 (ddH 2 0), as previously described 18, 19 . IHC for E. coli was performed on an intelliPATH autostainer (Biocare Medical): following incubation with blocking buffer (0.25% casein in tris-buffered saline (TBS) with 0.05% Tween-20) for 10 min and an endogenous peroxidase block of 1.5% (vol/vol) H 2 O 2 in TBS (pH 7.4) for 10 min, slides were incubated with a rabbit polyclonal E. coli antibody (Dako, B0357; 3.8μ g/ml) diluted in blocking buffer for 1 h at room temperature and detected using a biotin-free anti-rabbit Polink-1 HRP polymer system (Golden Bridge International, Inc.) for 30 min at room temperature in conjunction with DAB (3,3′ -diaminobenzidine; Vector Laboratories) for 2-5 min. IHC for Claudin-3 was performed as above with the following modifications: slides were stained manually with a rabbit polyclonal Claudin-3 antibody (Thermo Scientific, RB-9251-p; 1 μ g/ml) for 1 h at room temperature. The slides were developed as described above. All slides were washed in ddH 2 O, counterstained with hematoxylin, mounted with Permount (Fisher Scientific) and scanned at high magnification ( × 200) using a whole-slide scanning microscope (Aperio AT2 System, Aperio Technologies), yielding high-resolution data from the entire tissue section. For E. coli quantification, representative regions of interest (500 × 500 μ m) were extracted from the whole-tissue scans and the percent area of the anatomical site of interest (lamina propria of the GI tract, T cell zone of the LN) was quantified using Photoshop CS5 or CS6 (Adobe Systems, San Jose, CA) and Fovea (Reindeer Graphics, Asheville, NC) image analysis tools as previously described 18, 19 . Claudin-3 staining was used to visualize epithelial tight junctions so as to quantify epithelial barrier integrity (percent damage) as previously described 18, 19 .
ELISAs. Concentrations of sCD14 and IL-6 were quantified from plasma using a commercially available ELISA kits (R&D DC140 and HS600B, respectively), according to the manufacturers' protocols.
Short-chain fatty acids.
Fecal short-chain fatty acid concentrations were determined by gas chromatography (GC; Thermo Trace 1310 with TG-WAXMS A GC, 30 m, 0.32 mm, and 0.25 μ m columns), by Creative Proteomics (division of Creative Dynamics; Shirley, NY). Fecal pellets were homogenized in 17% (wt/wt) water suspension, and titrated to pH 2.0 using 5 M HCl. Fecal debris were pelleted and removed by centrifugation. The remaining supernatant was spiked with internal standard 2-Ethylbutyric acid. Samples were injected into the GC flame ionization detector and calibrated against a cocktail of standardized SCFAs-sodium propionate and acetic, butyric, isobutyric, valeric, isovaleric, hexanoic, and heptanoic acids. Peaks were assigned using the Chromeleon 7.2 software (Thermo), based on retention times of individual SCFA components. Chromeleon automatically determined mM concentrations of sample peaks using peak integration.
VL and cell-associated viremia. Plasma viral RNA (vRNA) levels were determined by qRT-PCR (ABI Prism 7900 sequence detection system; Applied Biosystems). vRNA was reverse transcribed and cDNA-amplified (45 cycles/default setting) with AmpliTaq Gold DNA polymerase (PCR core reagents kit; Perkin-Elmer/ Roche) using primer pairs corresponding to SIV mac239 gag gene sequences (forward, nucleotides 1181-1208, and reverse, 1338-1317). Cell-associated viral DNA within sorted CD4 TM cells was measured as previously 20 . Briefly, qRT-PCR was performed on sorted, lysed cells using the Taq DNA polymerase kit (Invitrogen) and the SIV mac239 forward primer GTCTGCGTCATYTGGTGCATTC, reverse primer CACTAGYTGTCTCTGCACTATRTGTTTTG, and probe sequence CTTCRTCAGTYTGTTTCACTTTCTCTTCTGCG.
Statistical analysis. Statistical analyses of viremia, single-parameter lymphocyte phenotype and function, and single microbial taxa frequency were performed using Prism (v7.0, GraphPad Software Inc.). Multiple t-tests (unpaired, twoway, with no correction for multiple tests or assumption of consistent s.d.) were used for comparisons between groups; paired t-tests were used for intragroup comparisons. Averaged longitudinal data are presented as arithmetic mean ± s.e.m. (SEM). Significance of polyfunctional cytokine expression was assessed using the Spice (v5.35; NIAID) permutation-test on relative expression values. Frequencies of microbial taxa are calculated relative to all returned bacterial OTUs mapping to non-mitochondrial (Rickettsiales Mitochondria) taxa. Microbial diversity was assessed by Chao1, Shannon, and unweighted and weighted Unifrac with statistical significance assessed by unpaired, two-way t-test for alpha indices and PERMANOVA (R-vegan function Adonis) for Unifrac distances. The empirical identification of differentially abundant bacterial taxa between groups was determined using the LEFSE algorithim 21 one-against-all multiclass analysis, normalized to 10 6 reads. PCoA plot of d115 p.i. Unweighted UNIFRAC distances generated by XLSTAT (Addinsoft v2017.5). PICRUSt-predicted metagenomic profiles were analyzed by STAMP 22 , with significance assed by Welch's t-test with Storey's FDR (reported *P < 0.05, effect size > 0.5). No data that met minimum threshold requirements as outlined in the Methods were excluded.
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